Hastürk, B. Et Al. 2024. N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma. MOLECULAR BIOLOGY , vol.58, no.6 , 1280-1292.

Hastürk, B., Avşar, T., Özbaş, S., Yılmaz, B., & Eren, F., (2024). N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma. MOLECULAR BIOLOGY , vol.58, no.6, 1280-1292.

Hastürk, Burcu Et Al. "N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma," MOLECULAR BIOLOGY , vol.58, no.6, 1280-1292, 2024

Hastürk, Burcu Et Al. "N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma." MOLECULAR BIOLOGY , vol.58, no.6, pp.1280-1292, 2024

Hastürk, B. Et Al. (2024) . "N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma." MOLECULAR BIOLOGY , vol.58, no.6, pp.1280-1292.

@article{article, author={Burcu Hastürk Et Al. }, title={N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma}, journal={MOLECULAR BIOLOGY}, year=2024, pages={1280-1292} }